Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M235,881Revenue $M53,634Net Margin (%)39.1Altman Z-Score4.2
Enterprise Value $M242,364EPS $4.1Operating Margin %20.9Piotroski F-Score6
P/E(ttm)24.1Beneish M-Score-2.8Pre-tax Margin (%)22.9Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %1.3Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %-0.6Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow22.8y-y EBITDA Growth Rate %14.2ROA % (ttm)16.4Higher Current Ratio y-yY
Dividend Yield %2.7PEG--ROE % (ttm)29.1Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M2,399ROIC % (ttm)11.6Gross Margin Increase y-yN

Gurus Latest Trades with NVS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVSDodge & Cox 2015-03-31 Reduce-0.02%$91.67 - $103
($98.99)
$ 98.34-1%Reduce 0.58%50,032,795
NVSTweedy Browne 2015-03-31 Reduce-0.01%$91.67 - $103
($98.99)
$ 98.34-1%Reduce 2.19%260,217
NVSHOTCHKIS & WILEY 2015-03-31 Sold Out -0.0031%$91.67 - $103
($98.99)
$ 98.34-1%Sold Out0
NVSMario Gabelli 2015-03-31 Add$91.67 - $103
($98.99)
$ 98.34-1%Add 2.61%9,840
NVSKen Fisher 2015-03-31 Reduce$91.67 - $103
($98.99)
$ 98.34-1%Reduce 0.29%5,990,224
NVSRuane Cunniff 2014-12-31 Sold Out $85.02 - $96.65
($92.56)
$ 98.346%Sold Out0
NVSHOTCHKIS & WILEY 2014-09-30 Reduce-0.21%$85.25 - $94.8
($90.27)
$ 98.349%Reduce 98.51%9,646
NVSRuane Cunniff 2014-09-30 Buy $85.25 - $94.8
($90.27)
$ 98.349%New holding7,772
NVSHOTCHKIS & WILEY 2014-06-30 Reduce-0.52%$82.51 - $90.98
($87.73)
$ 98.3412%Reduce 71.80%649,519
NVSDodge & Cox 2014-06-30 Add0.4%$82.51 - $90.98
($87.73)
$ 98.3412%Add 10.04%51,102,219
NVSChris Davis 2013-09-30 Sold Out -0.01%$70.66 - $77.08
($73.84)
$ 98.3433%Sold Out0
NVSVanguard Health Care Fund 2013-06-30 Sold Out -0.2%$68.42 - $75.5
($72.61)
$ 98.3435%Sold Out0
NVSVanguard Health Care Fund 2013-03-31 Reduce-0.71%$63.3 - $71.32
($67.87)
$ 98.3445%Reduce 85.39%726,200
NVSKahn Brothers 2013-03-31 Reduce-0.1%$63.3 - $71.32
($67.87)
$ 98.3445%Reduce 21.03%33,456
NVSVanguard Health Care Fund 2012-12-31 Reduce-0.99%$58.97 - $63.96
($61.82)
$ 98.3459%Reduce 70.59%1,461,400
NVSDodge & Cox 2012-12-31 Add0.11%$58.97 - $63.96
($61.79)
$ 98.3459%Add 2.65%48,438,459
NVSKahn Brothers 2012-12-31 Add0.04%$58.97 - $63.96
($61.82)
$ 98.3459%Add 10.43%42,368
NVSHOTCHKIS & WILEY 2012-12-31 Reduce-0.02%$58.97 - $63.96
($61.82)
$ 98.3459%Reduce 1.98%2,313,613
NVSKen Fisher 2012-12-31 Reduce-0.01%$58.97 - $63.96
($61.82)
$ 98.3459%Reduce 0.93%5,038,879
NVSChris Davis 2012-12-31 Reduce$58.97 - $63.96
($61.82)
$ 98.3459%Reduce 0.09%33,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Novartis Bioventures Ltd10% Owner 2014-09-22Buy325,000$15555.6view

Quarterly/Annual Reports about NVS:

    News about NVS:

    Articles On GuruFocus.com
    Bill Frels' Stocks With Highest-Growing Yields Jun 26 2015 
    Bill Frels' Stocks With Growing Yields Jun 27 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Follow Bill Ackman in Valeant Pharmaceuticals Jun 19 2015 
    Billionaire George Soros Ups Two Stakes in First Quarter Jun 16 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
    8 Top Healthcare Stocks to Watch May 13 2015 
    Amgen Reports An Upbeat Q1 Earnings Apr 23 2015 
    Top Weighted Stocks in Tweedy Browne Global Value Fund's Portfolio Apr 22 2015 

    More From Other Websites
    Novartis (NVS) Stock Declines as U.S. Seeks $3.35 Billion Fine Jun 30 2015
    How Much?! Feds Wants Novartis to pay $3.35B For Kickback Schemes Jun 30 2015
    U.S. seeks up to $3.35 billion in Novartis kickback lawsuit Jun 30 2015
    Roche 'High Efficacy' MS Drug Succeeds In Trials Jun 30 2015
    Sony slides on share plan; Apple launches music service; Juno soars on Celgene deal Jun 30 2015
    Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog Jun 29 2015
    Early movers: NBG, JPM, M, GCI, TWTR & more Jun 29 2015
    Novartis to Pay at Least $200 Million for Chronic Pain Medicine Jun 29 2015
    Switzerland's Novartis buys US biotech firm Spinifex Jun 29 2015
    Novartis buys pain drug firm Spinifex for $200 mln upfront Jun 29 2015
    1:42 am Novartis announces journal publication indicating Phase III FUTURE 2 study of secukinumab in... Jun 29 2015
    New data fuel hopes for broad use of Novartis psoriasis drug Jun 28 2015
    External Innovation: Force Multiplier For R&D Jun 26 2015
    Europe gives green light to new Novartis, Alexion drugs Jun 26 2015
    Hagens Berman: Class Action Alleges Novartis Gleevec Patent Infringement Suit a Sham Jun 24 2015
    Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A Jun 23 2015
    GSK Vaccinates Pfizer to Gain Novartis - Video Blog Jun 23 2015
    GSK sells two meningitis drugs to Pfizer for £82m Jun 22 2015
    Novartis AG upgraded by Bryan Garnier Jun 22 2015
    Novartis AG (NVS) Stock Rises on Plan to Increase Profit Margin Jun 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK